|
Post by dreamboatcruise on Jul 9, 2015 10:47:50 GMT -5
mnkdnut... though if formularylookup.com is to be believed (not sure if that is something one should do), there are already 138 formulary plans that cover 4% of patients (under all the plans they cover) that have Afrezza at preferred status. I wonder if the ones that have already put it on preferred are simply Cadillac plans that put everything on preferred immediately, or whether there are some that have committee that actually understood the unique clinical value of Afrezza immediately. My guess would be: some plans will give it preferred status but with restrictions that the patient cannot tolerate or handle insulin injections (?) Or, your Cadillac guess may be a factor too. There's always outliers. My understanding of the formularylookup classification is if there is a restriction that requires a doctor to document that a patient meets some criteria then it would not be listed as "prefered", it would be listed as "restricted". Whether their method of collecting the data does so accurately is certainly a question.
|
|